NYSEMKT: OSTX
Os Therapies Inc Stock Ownership - Who owns Os Therapies?

Insider buying vs selling

Have Os Therapies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Shalom Auerbach10% Owner2025-05-0782,000$2.00
$163.92kSell
Shalom Auerbach10% Owner2025-04-1010,000$1.39
$13.90kSell
Shalom Auerbach10% Owner2025-04-0950,012$1.35
$67.67kSell
Shalom Auerbach10% Owner2025-02-27225,000$1.64
$369.00kSell
Shalom Auerbach10% Owner2025-02-14100,000$2.84
$284.30kSell
Shalom Auerbach10% Owner2025-01-1516,720$6.74
$112.61kSell

1 of 1

OSTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OSTX insiders and whales buy or sell their stock.

OSTX Shareholders

What type of owners hold Os Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shalom Auerbach7.63%2,687,570$5.16MInsider
Paul A. Romness7.02%2,473,000$4.75MInsider
John Ciccio1.29%455,835$875.20kInsider
Theodore F. Search1.29%455,835$875.20kInsider
CM Management LLC1.14%400,000$768.00kInstitution
Colin Goddard0.64%225,179$432.34kInsider
Robert Petit0.57%200,000$384.00kInsider
Marshall Wace LLP0.56%198,552$381.22kInstitution
Vanguard Group Inc0.53%188,263$361.46kInstitution
Geode Capital Management LLC0.53%187,688$360.36kInstitution

1 of 3

OSTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OSTX4.44%18.75%Net Selling
MGX15.98%34.28%Net BuyingNet Buying
DTIL14.48%85.52%Net SellingNet Selling
NRXP7.36%92.64%Net Buying
KRRO25.74%74.26%

Os Therapies Stock Ownership FAQ

Who owns Os Therapies?

Os Therapies (NYSEMKT: OSTX) is owned by 4.44% institutional shareholders, 18.75% Os Therapies insiders, and 76.81% retail investors. Shalom Auerbach is the largest individual Os Therapies shareholder, owning 2.69M shares representing 7.63% of the company. Shalom Auerbach's Os Therapies shares are currently valued at $5.16M.

If you're new to stock investing, here's how to buy Os Therapies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.